RxDoctor Payments DataLook up a doctor →

Thomas Shiovitz

Psychiatry · Sherman Oaks, CANPI 1942309851

Payments from drug & device makers

$8,687,857in general payments, 2019–2025

Across 651 payments — averaging $13,345 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$3.5M
  • Biogen$1.9M
  • Genentech, Inc.$558K
  • Sage Therapeutics, LLC$534K
  • AbbVie$488K
  • Novartis$450K
  • plus $1.3M from 17 others
$217,526in research payments, 2019–2025

Across 16 payments — averaging $13,595 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Otsuka Pharmaceutical Development & Commercialization, Inc.$194K
  • Pfizer$20K
  • Eli Lilly$4K
  • Novo Nordisk AS$94

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$8,687,857 in reported general payments places this provider in the 95th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California

Other psychiatry in Sherman Oaks

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →